feed,title,long_url,short_url
Benzinga,FDA Extends Decision Date For Incyte's Ruxolitinib In Vitiligo Skin Disorder,https://benzinga.com/general/biotech/22/03/26124046/fda-extends-decision-date-for-incytes-ruxolitinib-in-vitiligo-skin-disorder,https://bit.ly/3w9neuf
Benzinga,Renewed Focus Clears Distractions for Chindata After Founder's Abrupt Exit,https://benzinga.com/markets/asia/22/03/26124922/renewed-focus-clears-distractions-for-chindata-after-founders-abrupt-exit,https://bit.ly/3tRPHSJ
